Literature DB >> 9808796

A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency.

Y Moriyama1, T Okamura, A Inazu, M Doi, H Iso, Y Mouri, Y Ishikawa, H Suzuki, M Iida, J Koizumi, H Mabuchi, Y Komachi.   

Abstract

BACKGROUND: Use of genetic analysis may improve the predictive value of risk factors for disease. A high plasma level of high-density lipoprotein (HDL) cholesterol is a strong negative risk factor for coronary heart disease (CHD). Cholesteryl ester transfer protein (CETP) deficiency causes increased levels of HDL cholesterol. However, recent studies suggest that CETP deficiency is a risk factor for CHD despite elevated HDL cholesterol levels.
METHODS: Plasma lipid levels, CHD prevalence, resting electrocardiograms, and common CETP gene mutations were analyzed cross-sectionally in a population of 19,044 male and 29,487 female Japanese subjects (ages 45-79 years).
RESULTS: High HDL cholesterol levels (serum HDL cholesterol >/=80 mg/dl, >/=95th percentile) were found in 6 and 5% of Japanese men and women, respectively. In the group with HDL cholesterol >/=80 mg/dl, common CETP gene mutations were identified in 23-24% of men and 31-49% of women. The prevalence of CHD in the group with high HDL cholesterol (>/=80 mg/dl) was low among both men (1.0%) and women (1.3%). There was no difference in CHD prevalence between hyper-HDL-cholesterolemic subjects with and without CETP mutations.
CONCLUSIONS: Subjects with very high HDL levels (HDL cholesterol >/=80 mg/dl) as well as mild-to-moderate HDL elevations (60-79 mg/dl) appear to be protected against CHD, whether or not they have CETP deficiency, a genetic cause of elevated HDL. Copyright 1998 American Health Foundation and Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9808796     DOI: 10.1006/pmed.1998.0340

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  36 in total

Review 1.  Reverse cholesterol transport: high-density lipoprotein's magnificent mile.

Authors:  Peter P Toth
Journal:  Curr Atheroscler Rep       Date:  2003-09       Impact factor: 5.113

Review 2.  Genetic causes of high and low serum HDL-cholesterol.

Authors:  Daphna Weissglas-Volkov; Päivi Pajukanta
Journal:  J Lipid Res       Date:  2010-04-26       Impact factor: 5.922

3.  An integrated approach for the mechanisms responsible for atherosclerotic plaque regression.

Authors:  Andrew A Francis; Grant N Pierce
Journal:  Exp Clin Cardiol       Date:  2011

Review 4.  HDL metabolism and the role of HDL in the treatment of high-risk patients with cardiovascular disease.

Authors:  H Bryan Brewer
Journal:  Curr Cardiol Rep       Date:  2007-11       Impact factor: 2.931

5.  Cholesteryl ester transfer protein, coronary calcium, and intima-media thickness of the carotid artery in middle-age Japanese men.

Authors:  Tomonori Okamura; Akira Sekikawa; Takashi Kadowaki; Aiman El-Saed; Robert D Abbott; J David Curb; Daniel Edmundowicz; Yasuyuki Nakamura; Kiyoshi Murata; Atsunori Kashiwagi; Kim Sutton-Tyrrell; Rhobert W Evans; Joseph M Zmuda; Hiroshi Maegawa; Atsushi Hozawa; Ken-Ichi Mitsunami; Yoshihiko Nishio; Iva Miljkovic-Gacic; Minoru Horie; Naomi Miyamatsu; Yoshitaka Murakami; Lewis H Kuller; Hirotsugu Ueshima
Journal:  Am J Cardiol       Date:  2009-07-18       Impact factor: 2.778

6.  Deficiency of Cholesteryl Ester Transfer Protein Protects Against Atherosclerosis in Rabbits.

Authors:  Jifeng Zhang; Manabu Niimi; Dongshan Yang; Jingyan Liang; Jie Xu; Tokuhide Kimura; Anna V Mathew; Yanhong Guo; Yanbo Fan; Tianqing Zhu; Jun Song; Rose Ackermann; Yui Koike; Anna Schwendeman; Liangxue Lai; Subramaniam Pennathur; Minerva Garcia-Barrio; Jianglin Fan; Y Eugene Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-04-20       Impact factor: 8.311

Review 7.  Newer pharmaceutical agents to treat lipid disorders.

Authors:  Michael H Davidson
Journal:  Curr Cardiol Rep       Date:  2003-11       Impact factor: 2.931

Review 8.  Inhibition of cholesteryl ester transfer protein activity: a new therapeutic approach to raising high-density lipoprotein.

Authors:  Daniel J Rader
Journal:  Curr Atheroscler Rep       Date:  2004-09       Impact factor: 5.113

Review 9.  Biologic therapies for dyslipidemia.

Authors:  Michael H Davidson
Journal:  Curr Atheroscler Rep       Date:  2004-01       Impact factor: 5.113

10.  Association of circulating cholesteryl ester transfer protein activity with incidence of cardiovascular disease in the community.

Authors:  Ramachandran S Vasan; Michael J Pencina; Sander J Robins; Justin P Zachariah; Guneet Kaur; Ralph B D'Agostino; Jose M Ordovas
Journal:  Circulation       Date:  2009-12-15       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.